Cargando…
Dramatic presentation of acquired thrombotic thrombocytopenic purpura associated with COVID-19
Autores principales: | Capecchi, Marco, Mocellin, Cristina, Abbruzzese, Chiara, Mancini, Ilaria, Prati, Daniele, Peyvandi, Flora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556657/ https://www.ncbi.nlm.nih.gov/pubmed/33054099 http://dx.doi.org/10.3324/haematol.2020.262345 |
Ejemplares similares
-
Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023) -
Efficacy and safety of azathioprine during remission of immune-mediated thrombotic thrombocytopenic purpura
por: Bichard, Christian, et al.
Publicado: (2022) -
Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
por: Riva, Silvia, et al.
Publicado: (2020) -
Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case–control study
por: Ferrari, Barbara, et al.
Publicado: (2014) -
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients
por: Capecchi, Marco, et al.
Publicado: (2023)